Lindsey Rearigh

Lindsey Rearigh

Auto-generated profile, based on publicly available information

Lindsey Rearigh

Division of Infectious Diseases, University of Nebraska Medical Center, Omaha, Nebraska

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 June 2020 in Annals of Hematology
Verified
Journal Article
Open access
PDF file
LRLindsey Rearigh
Lindsey Rearigh
ESErica Stohs
Erica Stohs
AFAlison Freifeld
Alison Freifeld
AZAndrea Zimmer
Andrea Zimmer
Febrile neutropenia (FN) is a common serious complication in patients undergoing hematopoietic stem cell transplantation (HSCT) requiring urgent evaluation and initiation of empiric broad spectrum antibiotics (BSA). The appropriate duration of BSA for FN in patients with negative cultures and no identifiable infection remains undefined. We retrospectively analyzed allogenic and autologous HSCT patients with FN and negative infectious work-up at our facility from 2012 to 2018. The early de-escalation group (EDG) included those who had BSA de-escalation to fluoroquinolone prophylaxis at least 24 h prior to absolute neutrophil count (ANC) recovery after the patient was fever-free for at least 48 h. Among 297 patients undergoing their first HSCT who experienced FN with negative infectious work-up, 83 patients were de-escalated early with the remaining 214 in the standard of care group (SCG) whose BSA were continued until ANC was > 500. Duration of broad-spectrum antibiotics was shorter in EDG compared to SCG (3.86 days vs. 4.62 days, p = 0.03). Rates of mortality, new infections, and clinical decompensation requiring intensive care unit transfer and/or pressor use within 30 days were all similar between the two groups (0% vs. 0.4% p = 1.00, 0% vs. 1.4% p = 0.56, 13.2% vs. 8.4% p = 0.27). This indicates that it is safe to de-escalate antibiotics prior to ANC recovery, leading to less BSA exposure.

3 August 2020 in Infection Control & Hospital Epidemiology
Verified
Journal Article
Open access
PDF file
LRLindsey M. Rearigh
Lindsey M. Rearigh
AHAngela L. Hewlett
Angela L. Hewlett
PFPaul D. Fey
Paul D. Fey
MBM. Jana Broadhurst
M. Jana Broadhurst
DBDavid M. Brett-Major
David M. Brett-Major
TSTrevor C. Van Schooneveld
Trevor C. Van Schooneveld
As the coronavirus disease 2019 (COVID-19) continues to circulate, testing strategies are of the utmost importance. Given national shortages of testing supplies, personal protective equipment, and other hospital resources, diagnostic stewardship is necessary to aid in resource management. We report the low utility of serial testing in a low-prevalence setting.

11 November 2019 in Journal of NeuroVirology
Verified
Journal Article
Closed access
PDF file
LRLindsey Rearigh
Lindsey Rearigh
SKSachin Kedar
Sachin Kedar
SBSara H. Bares
Sara H. Bares